Mankind Pharma Sees Significant Rise in Open Interest Amid Active Trading Dynamics

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable increase in open interest today. The latest open interest stands at 18,336 contracts, reflecting a rise of 2,110 contracts or 13.0% from the previous open interest of 16,226. This surge coincides with a trading volume of 18,835 contracts, indicating active participation in the derivatives market.
In terms of financial metrics, Mankind Pharma's future value is reported at Rs 37,904.24 lakhs, while the options value is significantly higher at Rs 72,091.15 lakhs, bringing the total value to Rs 38,273.04 lakhs. The underlying value of the stock is noted at Rs 2,563.

Despite this increase in open interest, Mankind Pharma's stock has underperformed its sector by 2.08% today, with a 1D return of -1.69%. The stock has also seen a trend reversal, falling after four consecutive days of gains. Notably, it remains above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, although delivery volume has decreased by 31.03% compared to the 5-day average.

In summary, Mankind Pharma's significant rise in open interest highlights active trading dynamics, even as the stock faces short-term challenges in performance relative to its sector.